Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Indivior Pharmaceuticals Inc. (INDV) had Weighted-Average Shares Outstanding (Diluted) of 130.00M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$358.00M |
|
$102.00M |
|
$66.00M |
|
$292.00M |
|
$276.00M |
|
$82.00M |
|
-- |
|
$81.00M |
|
$81.00M |
|
$102.00M |
|
$102.00M |
|
$102.00M |
|
$102.00M |
|
$82.00M |
|
-- |
|
124.39M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
130.00M |
$0.82 |
|
$0.79 |
|
| Balance Sheet Financials | |
$652.00M |
|
$144.00M |
|
$550.00M |
|
$1.20B |
|
$914.00M |
|
$290.00M |
|
$385.00M |
|
$1.30B |
|
$-99.00M |
|
$-101.00M |
|
$-98.00M |
|
125.00M |
|
| Cash Flow Statement Financials | |
$-27.00M |
|
$-66.00M |
|
$-30.00M |
|
$319.00M |
|
$195.00M |
|
$-124.00M |
|
$26.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|